These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8265878)

  • 1. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease.
    Argyropoulou P; Patakas D; Koukou A; Vasiliadis P; Georgopoulos D
    Respiration; 1993; 60(4):216-20. PubMed ID: 8265878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome.
    Eiser N; Denman WT; West C; Luce P
    Eur Respir J; 1991 Sep; 4(8):926-31. PubMed ID: 1783082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety.
    Singh NP; Despars JA; Stansbury DW; Avalos K; Light RW
    Chest; 1993 Mar; 103(3):800-4. PubMed ID: 8449072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.
    Marin JM; Carrizo SJ; Gascon M; Sanchez A; Gallego B; Celli BR
    Am J Respir Crit Care Med; 2001 May; 163(6):1395-9. PubMed ID: 11371407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease.
    Hay JG; Stone P; Carter J; Church S; Eyre-Brook A; Pearson MG; Woodcock AA; Calverley PM
    Eur Respir J; 1992 Jun; 5(6):659-64. PubMed ID: 1628722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease.
    Poole PJ; Veale AG; Black PN
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1877-80. PubMed ID: 9620921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin and perception of dyspnea in chronic airflow obstruction.
    Schiffman GL; Stansbury DW; Fischer CE; Sato RI; Light RW; Brown SE
    Am Rev Respir Dis; 1988 May; 137(5):1094-8. PubMed ID: 3195807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction.
    Foglio K; Carone M; Pagani M; Bianchi L; Jones PW; Ambrosino N
    Respir Med; 2000 Mar; 94(3):256-63. PubMed ID: 10783937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease.
    Light RW; Muro JR; Sato RI; Stansbury DW; Fischer CE; Brown SE
    Am Rev Respir Dis; 1989 Jan; 139(1):126-33. PubMed ID: 2492170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia.
    Dean NC; Brown JK; Himelman RB; Doherty JJ; Gold WM; Stulbarg MS
    Am Rev Respir Dis; 1992 Oct; 146(4):941-5. PubMed ID: 1416422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of dextromethorphan on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease (COPD).
    Giron AE; Stansbury DW; Fischer CE; Light RW
    Eur Respir J; 1991 May; 4(5):532-5. PubMed ID: 1936224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.
    Hajiro T; Nishimura K; Tsukino M; Ikeda A; Koyama H; Izumi T
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):785-90. PubMed ID: 9517591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
    Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
    Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide.
    Spence DP; Hay JG; Carter J; Pearson MG; Calverley PM
    Thorax; 1993 Nov; 48(11):1145-50. PubMed ID: 8296259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracoscopic lung volume reduction surgery reduces dyspnea and improves exercise capacity in patients with emphysema.
    Keller CA; Ruppel G; Hibbett A; Osterloh J; Naunheim KS
    Am J Respir Crit Care Med; 1997 Jul; 156(1):60-7. PubMed ID: 9230727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study.
    Li JS; Li SY; Yu XQ; Xie Y; Wang MH; Li ZG; Zhang NZ; Shao SJ; Zhang YJ; Zhu L; Guo LX; Bai YP; Wang YF
    J Ethnopharmacol; 2012 Jun; 141(2):584-91. PubMed ID: 21911051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease.
    Leung R; Hill P; Burdon J
    Thorax; 1996 Jun; 51(6):596-600. PubMed ID: 8693440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nebulized fenoterol on spirometry, dyspnea sensation changes during exercise in patients with chronic obstructive pulmonary disease.
    Chiang LL; Yu CT; Kuo HP
    Changgeng Yi Xue Za Zhi; 1996 Jun; 19(2):129-34. PubMed ID: 8828254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of orally administered retard morphine for therapy of severe pulmonary emphysema of the pink-puffer type. A pilot study].
    Schönhofer B; Köhler D
    Dtsch Med Wochenschr; 1998 Nov; 123(48):1433-8. PubMed ID: 9858950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.